Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01377064
Other study ID # Pro00007339
Secondary ID 1R21NR011281
Status Completed
Phase Phase 1
First received
Last updated
Start date March 2011
Est. completion date July 2013

Study information

Verified date April 2021
Source University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Because of advances in drug treatment, people living with HIV/AIDS (PLWHA) are living longer, but are also at greater risk for cardiovascular disease (CVD) and diabetes. Exercise and increased physical activity can reduce the risk factors for these diseases in PLWHA, but no studies have tested an at-home exercise program that would benefit low income people and others who do not have access to exercise facilities. This study will test the feasibility of an at-home exercise program for PLWHA and prepare for a full-scale intervention study, which may lead to a reduction in CVD risk among PLWHA.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 2013
Est. primary completion date July 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years and older - Medical diagnosis of HIV-1 positive serostatus - Sedentary lifestyle: not actively exercising = 3 d•wk-1 for 20 min per session - 18.5 kg/m2 < BMI < 40.0 kg/m2 - Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL - Capable of performing the required exercise regimen - Have daily access to a telephone for approximately 10 months - Capacity and willingness to provide informed consent and accept randomized group assignment Exclusion Criteria: - Individuals who have a clinical history strongly suggestive of Type 1 diabetes. - History of serious arrythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, myocardial infarction, or CABG. - Malignancies in the past 5 years, except therapeutically controlled skin cancer. - Plans to be away > 4 weeks in the next 9 months - Score of 5 or greater on the DAST or MAST (signifying excessive use of drugs or alcohol). - Weight loss in excess of 10% body weight in previous 12 weeks. - Chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric conditions. - Inflammatory-related conditions such as collagen disorders. - Any other medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise.

Study Design


Intervention

Behavioral:
Physical Activity Group
9 months of home based physical activity meeting HHS recommendations for physical activity for all americans
Other:
Standard Care Group
No intervention, the group will be followed under their standard medical care.

Locations

Country Name City State
United States The Citadel Charleston South Carolina
United States University of South Carolina Columbia South Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of South Carolina National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of Physical Activity Accelerometer data will be the primary means of determining the participants' physical activity levels. Participants will be instructed to wear the accelerometer at baseline, 4 months, and 9 months. The participants will be required to wear the accelerometer during the waking hours for seven consecutive days. Data from participants with at least four days and at least 10 hours per day will be included. 9 months
Secondary Cardiorespiratory Fitness Each participant will complete a graded exercise stress test (GXT) with indirect calorimetry. This test will be used to screen for abnormal physiological responses to exercise and for determining the participant's maximal ability to utilize oxygen (an index of cardiorespiratory fitness). 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2